Acciones Chinook Tyee Industry Ltd Toronto S.E.
Acciones
GBI.H
CA16961T2083
Farmacéuticos
Ventas 2022 | - | Ventas 2023 | - | Capitalización | 322 mil 236 mil 218 mil |
---|---|---|---|---|---|
Resultado Neto 2022 | -1 M -733 mil -675 mil | Resultado Neto 2023 | - 0 0 | VE / Ventas 2022 | - |
Deuda neta 2022 | 3,15 M 2,31 M 2,13 M | Deuda neta 2023 | 2,77 M 2,03 M 1,87 M | VE / Ventas 2023 | - |
P/E ratio 2022 |
-1,79
x | P/E ratio 2023 |
-1,08
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 74,11 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Investor Relations Contact | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Frank Otto
BRD | Director/Board Member | - | 11/05/22 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+43,31 % | 6192,92 M | |
-16,99 % | 4477,97 M | |
+6,39 % | 3294,72 M | |
-13,10 % | 3116,22 M | |
-4,17 % | 2495,58 M | |
+45,47 % | 1939,47 M | |
-9,11 % | 1684,8 M | |
-2,09 % | 1637,21 M | |
-12,50 % | 1561,4 M |